FDA Inspection 894511 — Biomat USA, Inc

Biomat USA, Inc — FEI 3006420574

The FDA completed an inspection of Biomat USA, Inc on August 27, 2014 in Calexico, CA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 2 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
August 27, 2014
Fiscal Year
2014
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Calexico, CA (United States)

Citations

IDCFRDescription
16021 CFR 606.160(a)(1)Person performing, test results, interpretation
33321 CFR 640.64(e)Prevention of contamination